Cowen Inc. announced that Steven Mah, Ph.D., has joined the Company's equity research team to further expand the firm's coverage of the life science & diagnostic tools sector. He will be based in New York, and will report to Robert Fagin, Cowen's Head of Research. Prior to joining Cowen, Dr. Mah was a senior analyst for life science & diagnostic tools at Piper Sandler, and earlier in his career was a Principal in Piper Sandler's health care investment banking group, where he focused on mergers and acquisitions as well as equity and equity-linked transactions.
1st Jan change | Capi. | |
---|---|---|
+4.92% | 159B | |
+6.51% | 134B | |
+21.13% | 119B | |
-8.59% | 35.44B | |
+10.10% | 25.44B | |
+25.74% | 21.38B | |
-9.13% | 19.99B | |
+54.98% | 18.02B | |
+4.03% | 15.6B |